28 Mar 2023 Cytonus expands its Scientific Advisory Board with mRNA expert Michael Houston, PhD Press Releases SAN DIEGO–(
28 Mar 2023 CANbridge Pharmaceuticals CAN008 Phase 2 Trial for Treatment of Glioblastoma Multiforme (GBM) in China Reaches Full Enrollment Press Releases
28 Mar 2023 Avacta Appoints Karen Harrison as Chief Operating Officer for Therapeutics Division Press Releases …
28 Mar 2023 Newron Presents Six-Month Interim Data From the First 100 Patients Randomized in Study 014/015 at the 31st European Congress of Psychiatry Press Releases
28 Mar 2023 Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib), a Once-Daily Oral Treatment for Adults With Moderate-to-Severe Plaque Psoriasis Press Releases PRINCETON,…
28 Mar 2023 Silence Therapeutics Appoints Dr. Steven Romano as Incoming Chief Medical Officer and Head of Research and Development Press Releases …
28 Mar 2023 Sonoma Biotherapeutics and Regeneron Announce Collaboration to Discover, Develop and Commercialize Treg Cell Therapies for Autoimmune Diseases Press Releases
28 Mar 2023 Prilenia Achieves Last Patient Last Visit in Phase 3 PROOF-HD Clinical Study for Huntington’s Disease Press Releases
28 Mar 2023 Simulations Plus Enters New Strategic Collaboration to Discover Anticancer Therapies Through Its AI-Driven Drug Design Technology Press Releases
